RETRACTED: Lung Fibrosis-associated Surfactant Protein A1 and C Variants Induce Latent Transforming Growth Factor β1 Secretion in Lung Epithelial Cells (Retracted Article)

Missense mutations of surfactant proteins are recognized as important causes of inherited lung fibrosis. Here, we study rare and common surfactant protein (SP)-A1 and SP-C variants, either discovered in our familial pulmonary fibrosis cohort or described by others. We show that expression of two SP-A1 (R219W and R242*) and three SP-C (I73T, M71V, and L188Q) variant proteins lead to the secretion of the profibrotic latent transforming growth factor (TGF)-beta 1 in lung epithelial cell lines. The secreted TGF-beta 1 is capable of autocrine and paracrine signaling and is dependent upon expression of the latent TGF-beta 1 binding proteins. The dependence upon unfolded protein response (UPR) mediators for TGF-beta 1 induction differs for each variant. TGF-beta 1 secretion induced by the expression of the common SP-A1 R219W variant is nearly completely blocked by silencing the UPR transducers IRE-1 beta and ATF6. In contrast, the secretion of TGF-beta 1 induced by two rare SP-C mutant proteins (I73T and M71V), is largely unaffected by UPR silencing or by the addition of the small molecular chaperone 4-phenylbutyric acid, implicating a UPR-independent mechanism for these variants. Blocking TGF-beta 1 secretion reverses cell death of RLE-6TN cells expressing these SP-A1 and SP-C variants suggesting that anti-TGF-beta therapeutics may be beneficial to this molecularly defined subgroup of pulmonary fibrosis patients.